GlassScriptPhysician profile
Vernita Newby Peeples
NPI 1417060591
$1,119.65
in general payments reported to CMS, 2019-2025
17 companies · $225 in 2025
The $225 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $91.32 · 2021: $56.90 · 2022: $24.29 · 2023: $111 · 2024: $134 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $163.49 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $140.70 | 2025 | Zoryve |
| Kaleo, INC. | $128.29 | 2019-2020 | |
| Phadia US INC. | $115.74 | 2021-2024 | Immunocap |
| Cranial Technologies, INC | $97.13 | 2019-2021 | |
| Glaxosmithkline, LLC. | $95.82 | 2019 | |
| Neurelis, INC. | $93.44 | 2023 | Valtoco |
| Ironshore Pharmaceuticals INC. | $61.89 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $41.76 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $40.02 | 2025 | Jornay Pm |
| Organon LLC | $27.31 | 2025 | Nexplanon |
| Shire North American Group INC | $21.95 | 2019 | |
| Corium, LLC | $19.87 | 2024 | Azstarys |
| Pfizer INC. | $18.95 | 2019 | |
| Abbott Laboratories | $18.25 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $17.96 | 2023 | Qelbree |
| Alk-Abello, INC | $17.08 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vernita Peeples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.